{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:52:41Z","timestamp":1778205161779,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Accurate identification of primary cancer origin in brain metastases (BMs) is crucial for diagnosis and treatment planning. Identification is challenging, particularly in unknown primary cases. Multiparametric Magnetic Resonance Imaging (MRI) offers non-invasive imaging characteristics as diagnostic clues. This study aimed to investigate the relationship between multiparametric MRI features of BMs and their primary tumor origin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective study included 125 patients with intra-axial brain metastases, classified as breast cancer, small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC), malignant melanoma, and other cancers. Multiparametric MRI, including T2-FLAIR, contrast-enhanced 3D T1-weighted imaging, apparent diffusion coefficient (ADC) maps, susceptibility-weighted imaging (SWI), and cerebral blood volume (CBV) maps, was performed. Lesion volume, necrotic volume, necrosis ratio, peritumoral edema volume, and edema ratio were measured. 3D Slicer<jats:sup>\u00ae<\/jats:sup> software was used for semi-automated volumetric measurements. Quantitative ADC and rCBV values, intratumoral susceptibility signal (ITSS) scores, and metastasis number and location were analyzed to differentiate primary tumor origins.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>291 metastatic lesions from 125 patients were analyzed. NSCLC metastases showed significantly higher necrosis ratios than breast (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and SCLC (<jats:italic>p<\/jats:italic>\u2009=\u20090.025) metastases. Malignant melanoma metastases exhibited significantly higher edema ratios than breast (<jats:italic>p<\/jats:italic>\u2009=\u20090.001) and SCLC (<jats:italic>p<\/jats:italic>\u2009=\u20090.004) metastases. NSCLC metastases also showed a significantly higher edema ratio than breast (<jats:italic>p<\/jats:italic>\u2009=\u20090.011) metastases. Mean ADC values were significantly higher in NSCLC metastases compared to all other groups, with an optimal cut-off of \u2265\u20090.905\u00a0mm\u00b2\/s (AUC: 0.775). Malignant melanoma and SCLC metastases had significantly higher rCBV values than breast cancer metastases. Malignant melanoma metastases consistently showed the highest ITSS scores among all groups, with an optimal cut-off of \u2265\u20091 (AUC: 0.769). Furthermore, multiple metastases\u2009\u2264\u20090.5\u00a0cm\u00b3 were significantly associated with breast cancer (<jats:italic>p<\/jats:italic>\u2009=\u20090.041). Infratentorial metastases were more prevalent in breast cancer (OR\u2009=\u20092.490, <jats:italic>p<\/jats:italic>\u2009=\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Brain metastases exhibit distinct multiparametric MRI characteristics by primary cancer origin. Breast cancer metastases tend to be smaller, multiple, and infratentorial. NSCLC metastases show greater necrosis and higher ADC values, while melanoma metastases demonstrate higher intratumoral susceptibility. These features offer valuable diagnostic clues for differentiating primary cancer types in patients with brain metastases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial number<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12880-025-01925-5","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:40:44Z","timestamp":1760524844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multiparametric MRI characteristics for differentiating primary cancer origin in brain metastases"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6157-6367","authenticated-orcid":false,"given":"Ali","family":"Salbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-898X","authenticated-orcid":false,"given":"Mehmet","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7878-6117","authenticated-orcid":false,"given":"Yusuf Kenan","family":"Cetinoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5564-2196","authenticated-orcid":false,"given":"Merve","family":"Horoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2190-5111","authenticated-orcid":false,"given":"Murat","family":"Yogurtcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6570-5808","authenticated-orcid":false,"given":"Anil","family":"Huvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1263-0918","authenticated-orcid":false,"given":"Mustafa Fazil","family":"Gelal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"1925_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nec.2020.06.001","volume":"31","author":"P Sacks","year":"2020","unstructured":"Sacks P, Rahman M. Epidemiology of brain metastases. Neurosurg Clin N Am. 2020;31:481\u20138. https:\/\/doi.org\/10.1016\/j.nec.2020.06.001.","journal-title":"Neurosurg Clin N Am"},{"key":"1925_CR2","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1158\/1078-0432.CCR-18-1624","volume":"25","author":"PE Fecci","year":"2019","unstructured":"Fecci PE, Champion CD, Hoj J, McKernan CM, Goodwin CR, Kirkpatrick JP, et al. The evolving modern management of brain metastasis. Clin Cancer Res. 2019;25:6570\u201380. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1624.","journal-title":"Clin Cancer Res"},{"key":"1925_CR3","first-page":"4655","volume":"32","author":"E Tabouret","year":"2012","unstructured":"Tabouret E, Chinot O, Metellus P, Tallet A, Viens P, Gon\u00e7alves A. Recent trends in epidemiology of brain metastases: an overview. Anticancer Res. 2012;32:4655\u201362.","journal-title":"Anticancer Res"},{"key":"1925_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.canrad.2014.11.001","volume":"19","author":"S Taillibert","year":"2015","unstructured":"Taillibert S, Le Rhun \u00c9. \u00c9pid\u00e9miologie des l\u00e9sions m\u00e9tastatiques c\u00e9r\u00e9brales. Cancer\/Radioth\u00e9rapie. 2015;19:3\u20139. https:\/\/doi.org\/10.1016\/j.canrad.2014.11.001.","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"1925_CR5","doi-asserted-by":"publisher","unstructured":"Balestrino R, Rud\u00e0 R, Soffietti R. Brain metastasis from unknown primary tumour: moving from old retrospective studies to clinical trials on targeted agents. Cancers (Basel). 2020;12. https:\/\/doi.org\/10.3390\/cancers12113350.","DOI":"10.3390\/cancers12113350"},{"key":"1925_CR6","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0140-6736(11)61178-1","volume":"379","author":"N Pavlidis","year":"2012","unstructured":"Pavlidis N, Pentheroudakis G. Cancer of unknown primary site. Lancet. 2012;379:1428\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(11)61178-1.","journal-title":"Lancet"},{"key":"1925_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejca.2021.12.005","volume":"162","author":"A Steindl","year":"2022","unstructured":"Steindl A, Brunner TJ, Heimbach K, Schweighart K, Moser GM, Niziolek HM, et al. Changing characteristics, treatment approaches and survival of patients with brain metastasis: data from six thousand and thirty-one individuals over an observation period of 30 years. Eur J Cancer. 2022;162:170\u201381. https:\/\/doi.org\/10.1016\/j.ejca.2021.12.005.","journal-title":"Eur J Cancer"},{"key":"1925_CR8","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/jmri.28695","volume":"58","author":"T Jiao","year":"2023","unstructured":"Jiao T, Li F, Cui Y, Wang X, Li B, Shi F, et al. Deep learning with an attention mechanism for differentiating the origin of brain metastasis using MR images. J Magn Reson Imaging. 2023;58:1624\u201335. https:\/\/doi.org\/10.1002\/jmri.28695.","journal-title":"J Magn Reson Imaging"},{"key":"1925_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12880-025-01703-3","volume":"25","author":"C Kong","year":"2025","unstructured":"Kong C, Yan D, Liu K, Yin Y, Ma C. Multiple deep learning models based on MRI images in discriminating glioblastoma from solitary brain metastases: a multicentre study. BMC Med Imaging. 2025;25:171. https:\/\/doi.org\/10.1186\/s12880-025-01703-3.","journal-title":"BMC Med Imaging"},{"key":"1925_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12880-025-01712-2","volume":"25","author":"Z Chen","year":"2025","unstructured":"Chen Z, Chen Y, Su Y, Jiang N, Wanggou S, Li X. Machine learning decision support model construction for craniotomy approach of pineal region tumors based on MRI images. BMC Med Imaging. 2025;25:194. https:\/\/doi.org\/10.1186\/s12880-025-01712-2.","journal-title":"BMC Med Imaging"},{"key":"1925_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12880-024-01285-6","volume":"24","author":"A Alshuhail","year":"2024","unstructured":"Alshuhail A, Thakur A, Chandramma R, Mahesh TR, Almusharraf A, Vinoth Kumar V, et al. Refining neural network algorithms for accurate brain tumor classification in MRI imagery. BMC Med Imaging. 2024;24:118. https:\/\/doi.org\/10.1186\/s12880-024-01285-6.","journal-title":"BMC Med Imaging"},{"key":"1925_CR12","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.3390\/cancers13122960","volume":"13","author":"A-J Fordham","year":"2021","unstructured":"Fordham A-J, Hacherl C-C, Patel N, Jones K, Myers B, Abraham M, et al. Differentiating glioblastomas from solitary brain metastases: an update on the current literature of advanced imaging modalities. Cancers (Basel). 2021;13:2960. https:\/\/doi.org\/10.3390\/cancers13122960.","journal-title":"Cancers (Basel)"},{"key":"1925_CR13","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3390\/cancers14071694","volume":"14","author":"J Yoo","year":"2022","unstructured":"Yoo J, Cha YJ, Park HH, Park M, Joo B, Suh SH, et al. The extent of necrosis in brain metastases May predict subtypes of primary cancer and overall survival in patients receiving craniotomy. Cancers (Basel). 2022;14:1694. https:\/\/doi.org\/10.3390\/cancers14071694.","journal-title":"Cancers (Basel)"},{"key":"1925_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.21873\/anticanres.11392","volume":"37","author":"J Kerschbaumer","year":"2017","unstructured":"Kerschbaumer J, Bauer M, Popovscaia M, Grams AE, Thom\u00e9 C, Freyschlag CF. Correlation of tumor and peritumoral edema volumes with survival in patients with cerebral metastases. Anticancer Res. 2017;37:871\u20136. https:\/\/doi.org\/10.21873\/anticanres.11392.","journal-title":"Anticancer Res"},{"key":"1925_CR15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging. 2012;30:1323\u201341. https:\/\/doi.org\/10.1016\/j.mri.2012.05.001.","journal-title":"Magn Reson Imaging"},{"key":"1925_CR16","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3174\/ajnr.A1593","volume":"30","author":"MJ Park","year":"2009","unstructured":"Park MJ, Kim HS, Jahng G-H, Ryu C-W, Park SM, Kim SY. Semiquantitative assessment of intratumoral susceptibility signals using Non-Contrast-Enhanced High-Field High-Resolution susceptibility-Weighted imaging in patients with gliomas: comparison with MR perfusion imaging. Am J Neuroradiol. 2009;30:1402\u20138. https:\/\/doi.org\/10.3174\/ajnr.A1593.","journal-title":"Am J Neuroradiol"},{"key":"1925_CR17","doi-asserted-by":"publisher","unstructured":"Lee SY, Ju MK, Jeon HM, Jeong EK, Lee YJ, Kim CH et al. Regulation of tumor progression by programmed necrosis. Oxid Med Cell Longev. 2018;2018. https:\/\/doi.org\/10.1155\/2018\/3537471","DOI":"10.1155\/2018\/3537471"},{"key":"1925_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00701-021-05026-4","volume":"164","author":"A Michel","year":"2022","unstructured":"Michel A, Dinger T, Darkwah Oppong M, Rauschenbach L, Deuschl C, Ahmadipour Y, et al. Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome. Acta Neurochir (Wien). 2022;164:439\u201349. https:\/\/doi.org\/10.1007\/s00701-021-05026-4.","journal-title":"Acta Neurochir (Wien)"},{"key":"1925_CR19","doi-asserted-by":"publisher","unstructured":"Grazzini I, Venezia D, Del Roscio D, Chiarotti I, Mazzei MA, Cerase A. Morphological and functional neuroradiology of brain metastases. Semin Ultrasound CT MRI. 2023;44:170\u201393. https:\/\/doi.org\/10.1053\/j.sult.2023.03.004","DOI":"10.1053\/j.sult.2023.03.004"},{"key":"1925_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000447517","volume":"91","author":"K F\u00e1bi\u00e1n","year":"2016","unstructured":"F\u00e1bi\u00e1n K, Gyulai M, Fur\u00e1k J, V\u00e1rallyay P, J\u00e4ckel M, Bogos K, et al. Significance of primary tumor location and histology for brain metastasis development and peritumoral brain edema in lung cancer. Oncology. 2016;91:237\u201342. https:\/\/doi.org\/10.1159\/000447517.","journal-title":"Oncology"},{"key":"1925_CR21","doi-asserted-by":"publisher","first-page":"100391","DOI":"10.1016\/j.wnsx.2024.100391","volume":"23","author":"D Armocida","year":"2024","unstructured":"Armocida D, Zancana G, Bianconi A, Cofano F, Pesce A, Ascenzi BM, et al. Brain metastases: comparing clinical radiological differences in patients with lung and breast cancers treated with surgery. World Neurosurg X. 2024;23:100391. https:\/\/doi.org\/10.1016\/j.wnsx.2024.100391.","journal-title":"World Neurosurg X"},{"key":"1925_CR22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s40425-019-0684-z","volume":"7","author":"TT Tran","year":"2019","unstructured":"Tran TT, Mahajan A, Chiang VL, Goldberg SB, Nguyen DX, Jilaveanu LB, et al. Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapy. J Immunother Cancer. 2019;7:200. https:\/\/doi.org\/10.1186\/s40425-019-0684-z.","journal-title":"J Immunother Cancer"},{"key":"1925_CR23","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.clinimag.2015.06.015","volume":"39","author":"H-J Meyer","year":"2015","unstructured":"Meyer H-J, Fiedler E, Kornhuber M, Spielmann RP, Surov A. Comparison of diffusion-weighted imaging findings in brain metastases of different origin. Clin Imaging. 2015;39:965\u20139. https:\/\/doi.org\/10.1016\/j.clinimag.2015.06.015.","journal-title":"Clin Imaging"},{"key":"1925_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12880-021-00602-7","volume":"21","author":"SJ M\u00fcller","year":"2021","unstructured":"M\u00fcller SJ, Khadhraoui E, Neef NE, Riedel CH, Ernst M. Differentiation of brain metastases from small and non-small lung cancers using apparent diffusion coefficient (ADC) maps. BMC Med Imaging. 2021;21:70. https:\/\/doi.org\/10.1186\/s12880-021-00602-7.","journal-title":"BMC Med Imaging"},{"key":"1925_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neurad.2018.09.006","volume":"46","author":"K Askaner","year":"2019","unstructured":"Askaner K, Rydelius A, Engelholm S, Knutsson L, L\u00e4tt J, Abul-Kasim K, et al. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T. J Neuroradiol. 2019;46:367\u201372. https:\/\/doi.org\/10.1016\/j.neurad.2018.09.006.","journal-title":"J Neuroradiol"},{"key":"1925_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/cam4.1046","volume":"6","author":"V Hatzoglou","year":"2017","unstructured":"Hatzoglou V, Tisnado J, Mehta A, Peck KK, Daras M, Omuro AM, et al. Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases. Cancer Med. 2017;6:761\u20137. https:\/\/doi.org\/10.1002\/cam4.1046.","journal-title":"Cancer Med"},{"key":"1925_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/153303461000900403","volume":"9","author":"BY Huang","year":"2010","unstructured":"Huang BY, Kwock L, Castillo M, Smith JK. Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility Contrast-enhanced perfusion weighted MRI. Technol Cancer Res Treat. 2010;9:327\u201337. https:\/\/doi.org\/10.1177\/153303461000900403.","journal-title":"Technol Cancer Res Treat"},{"key":"1925_CR28","doi-asserted-by":"publisher","first-page":"17080","DOI":"10.1038\/s41598-019-53629-w","volume":"9","author":"L-W Kong","year":"2019","unstructured":"Kong L-W, Chen J, Zhao H, Yao K, Fang S-Y, Wang Z, et al. Intratumoral susceptibility signals reflect biomarker status in gliomas. Sci Rep. 2019;9:17080. https:\/\/doi.org\/10.1038\/s41598-019-53629-w.","journal-title":"Sci Rep"},{"key":"1925_CR29","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1016\/j.ejrad.2012.06.016","volume":"81","author":"A Radbruch","year":"2012","unstructured":"Radbruch A, Graf M, Kramp L, Wiestler B, Floca R, B\u00e4umer P, et al. Differentiation of brain metastases by percentagewise quantification of intratumoral-susceptibility-signals at 3Tesla. Eur J Radiol. 2012;81:4064\u20138. https:\/\/doi.org\/10.1016\/j.ejrad.2012.06.016.","journal-title":"Eur J Radiol"},{"key":"1925_CR30","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/RCT.0000000000000420","volume":"40","author":"AM Franceschi","year":"2016","unstructured":"Franceschi AM, Moschos SJ, Anders CK, Glaubiger S, Collichio FA, Lee CB, et al. Use of Susceptibility-Weighted imaging (SWI) in the detection of brain hemorrhagic metastases from breast cancer and melanoma. J Comput Assist Tomogr. 2016;40:803\u20135. https:\/\/doi.org\/10.1097\/RCT.0000000000000420.","journal-title":"J Comput Assist Tomogr"},{"key":"1925_CR31","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/jmri.26692","volume":"50","author":"D Schwarz","year":"2019","unstructured":"Schwarz D, Niederle T, M\u00fcnch P, Hielscher T, Hassel JC, Schlemmer H, et al. Susceptibility-weighted imaging in malignant melanoma brain metastasis. J Magn Reson Imaging. 2019;50:1251\u20139. https:\/\/doi.org\/10.1002\/jmri.26692.","journal-title":"J Magn Reson Imaging"},{"key":"1925_CR32","doi-asserted-by":"publisher","unstructured":"Pope WB. Brain metastases: neuroimaging. In: Handbook of clinical neurology. 2018:89\u2013112. https:\/\/doi.org\/10.1016\/B978-0-12-811161-1.00007-4","DOI":"10.1016\/B978-0-12-811161-1.00007-4"},{"key":"1925_CR33","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41416-021-01424-8","volume":"125","author":"Y Wang","year":"2021","unstructured":"Wang Y, Ye F, Liang Y, Yang Q. Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies. Br J Cancer. 2021;125:1056\u201367. https:\/\/doi.org\/10.1038\/s41416-021-01424-8.","journal-title":"Br J Cancer"},{"key":"1925_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11060-020-03419-6","volume":"147","author":"T Schroeder","year":"2020","unstructured":"Schroeder T, Bittrich P, Kuhne JF, Noebel C, Leischner H, Fiehler J, et al. Mapping distribution of brain metastases: does the primary tumor matter? J Neurooncol. 2020;147:229\u201335. https:\/\/doi.org\/10.1007\/s11060-020-03419-6.","journal-title":"J Neurooncol"},{"key":"1925_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13020324","volume":"13","author":"Z Dou","year":"2021","unstructured":"Dou Z, Wu J, Wu H, Yu Q, Yan F, Jiang B, et al. The infratentorial localization of brain metastases May correlate with specific clinical characteristics and portend worse outcomes based on voxel-wise mapping. Cancers (Basel). 2021;13:1\u201316. https:\/\/doi.org\/10.3390\/cancers13020324.","journal-title":"Cancers (Basel)"},{"key":"1925_CR36","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1227\/01.NEU.0000182763.16246.60","volume":"57","author":"AK Sills","year":"2005","unstructured":"Sills AK. Current treatment approaches to surgery for brain metastases. Neurosurgery. 2005;57:S4\u201324. https:\/\/doi.org\/10.1227\/01.NEU.0000182763.16246.60.","journal-title":"Neurosurgery"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01925-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01925-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01925-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:40:45Z","timestamp":1760524845000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01925-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1925"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01925-5","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Ethics Committee (Health Research Ethics Committee of Izmir Katip Celebi University, application number 2024-SAEK-0129, dated 19\/09\/2024, Decision no: 0112) and was conducted in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The ethics committee (Health Research Ethics Committee of Izmir Katip Celebi University) waived informed consent due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"415"}}